VBI Vaccines Inc. (NASDAQ: VBIV) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
VBI Vaccines Inc. (NASDAQ: VBIV) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
BRII-835 + BRII-179 for Chronic Hepatitis B in 7MM: Market Size, Forecast, and Emerging Insights 2019-2032 [Yahoo! Finance]
VBI Vaccines Inc. (NASDAQ: VBIV) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
VBI Vaccines Reports Full Year 2023 Financial Results [Yahoo! Finance]